Cargando…

A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile

Epigallocatechin-3-gallate (EGCG), the major catechin present in green tea, presents diverse appealing biological activities, such as antioxidative, anti-inflammatory, antimicrobial, and antiviral activities, among others. The present work evaluated the impact in the molecular profile of human plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Rúben, Ramalhete, Luís, Da Paz, Helder, Ribeiro, Edna, Calado, Cecília R.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349803/
https://www.ncbi.nlm.nih.gov/pubmed/32283584
http://dx.doi.org/10.3390/ht9020009
_version_ 1783557139379257344
author Araújo, Rúben
Ramalhete, Luís
Da Paz, Helder
Ribeiro, Edna
Calado, Cecília R.C.
author_facet Araújo, Rúben
Ramalhete, Luís
Da Paz, Helder
Ribeiro, Edna
Calado, Cecília R.C.
author_sort Araújo, Rúben
collection PubMed
description Epigallocatechin-3-gallate (EGCG), the major catechin present in green tea, presents diverse appealing biological activities, such as antioxidative, anti-inflammatory, antimicrobial, and antiviral activities, among others. The present work evaluated the impact in the molecular profile of human plasma from daily consumption of 225 mg of EGCG for 90 days. Plasma from peripheral blood was collected from 30 healthy human volunteers and analyzed by high-throughput Fourier transform infrared spectroscopy. To capture the biochemical information while minimizing the interference of physical phenomena, several combinations of spectra pre-processing methods were evaluated by principal component analysis. The pre-processing method that led to the best class separation, that is, between the plasma spectral data collected at the beginning and after the 90 days, was a combination of atmospheric correction with a second derivative spectra. A hierarchical cluster analysis of second derivative spectra also highlighted the fact that plasma acquired before EGCG consumption presented a distinct molecular profile after the 90 days of EGCG consumption. It was also possible by partial least squares regression discriminant analysis to correctly predict all unlabeled plasma samples (not used for model construction) at both timeframes. We observed that the similarity in composition among the plasma samples was higher in samples collected after EGCG consumption when compared with the samples taken prior to EGCG consumption. Diverse negative peaks of the normalized second derivative spectra, associated with lipid and protein regions, were significantly affected (p < 0.001) by EGCG consumption, according to the impact of EGCG consumption on the patients’ blood, low density and high density lipoproteins ratio. In conclusion, a single bolus dose of 225 mg of EGCG, ingested throughout a period of 90 days, drastically affected plasma molecular composition in all participants, which raises awareness regarding prolonged human exposure to EGCG. Because the analysis was conducted in a high-throughput, label-free, and economic analysis, it could be applied to high-dimension molecular epidemiological studies to further promote the understanding of the effect of bio-compound consumption mode and frequency.
format Online
Article
Text
id pubmed-7349803
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73498032020-07-15 A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile Araújo, Rúben Ramalhete, Luís Da Paz, Helder Ribeiro, Edna Calado, Cecília R.C. High Throughput Article Epigallocatechin-3-gallate (EGCG), the major catechin present in green tea, presents diverse appealing biological activities, such as antioxidative, anti-inflammatory, antimicrobial, and antiviral activities, among others. The present work evaluated the impact in the molecular profile of human plasma from daily consumption of 225 mg of EGCG for 90 days. Plasma from peripheral blood was collected from 30 healthy human volunteers and analyzed by high-throughput Fourier transform infrared spectroscopy. To capture the biochemical information while minimizing the interference of physical phenomena, several combinations of spectra pre-processing methods were evaluated by principal component analysis. The pre-processing method that led to the best class separation, that is, between the plasma spectral data collected at the beginning and after the 90 days, was a combination of atmospheric correction with a second derivative spectra. A hierarchical cluster analysis of second derivative spectra also highlighted the fact that plasma acquired before EGCG consumption presented a distinct molecular profile after the 90 days of EGCG consumption. It was also possible by partial least squares regression discriminant analysis to correctly predict all unlabeled plasma samples (not used for model construction) at both timeframes. We observed that the similarity in composition among the plasma samples was higher in samples collected after EGCG consumption when compared with the samples taken prior to EGCG consumption. Diverse negative peaks of the normalized second derivative spectra, associated with lipid and protein regions, were significantly affected (p < 0.001) by EGCG consumption, according to the impact of EGCG consumption on the patients’ blood, low density and high density lipoproteins ratio. In conclusion, a single bolus dose of 225 mg of EGCG, ingested throughout a period of 90 days, drastically affected plasma molecular composition in all participants, which raises awareness regarding prolonged human exposure to EGCG. Because the analysis was conducted in a high-throughput, label-free, and economic analysis, it could be applied to high-dimension molecular epidemiological studies to further promote the understanding of the effect of bio-compound consumption mode and frequency. MDPI 2020-04-09 /pmc/articles/PMC7349803/ /pubmed/32283584 http://dx.doi.org/10.3390/ht9020009 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Araújo, Rúben
Ramalhete, Luís
Da Paz, Helder
Ribeiro, Edna
Calado, Cecília R.C.
A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title_full A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title_fullStr A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title_full_unstemmed A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title_short A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
title_sort simple, label-free, and high-throughput method to evaluate the epigallocatechin-3-gallate impact in plasma molecular profile
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349803/
https://www.ncbi.nlm.nih.gov/pubmed/32283584
http://dx.doi.org/10.3390/ht9020009
work_keys_str_mv AT araujoruben asimplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT ramalheteluis asimplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT dapazhelder asimplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT ribeiroedna asimplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT caladoceciliarc asimplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT araujoruben simplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT ramalheteluis simplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT dapazhelder simplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT ribeiroedna simplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile
AT caladoceciliarc simplelabelfreeandhighthroughputmethodtoevaluatetheepigallocatechin3gallateimpactinplasmamolecularprofile